Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges

Figure 5

One typical case of the patient who successfully finished the scheduled anticancer treatment plan with the thrombopoietic effect of avatrombopag. (a) Platelet count, avatrombopag dose, the AFP level, and anticancer treatment over time; (b) changes in enhanced MRI of the patient with HCC.

(a)

(b)